Last 0.30 NOK
Change Today 0.00 / 0.00%
Volume 0.0
CELL On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 10:25 AM 01/19/15 All times are local (Market data is delayed by at least 15 minutes).

cellcura asa (CELL) Snapshot

Open
0.29 NOK
Previous Close
0.30 NOK
Day High
0.30 NOK
Day Low
0.28 NOK
52 Week High
03/5/14 - 4.79 NOK
52 Week Low
12/15/14 - 0.18 NOK
Market Cap
2.0M
Average Volume 10 Days
2.0K
EPS TTM
-5.80 NOK
Shares Outstanding
6.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CELLCURA ASA (CELL)

Related News

No related news articles were found.

cellcura asa (CELL) Related Businessweek News

No Related Businessweek News Found

cellcura asa (CELL) Details

CellCura ASA develops and sells equipment and products for use in assisted reproductive technology (ART) and stem cell research applications worldwide. The company offers CellCura ART lab solution, a track and trace system, which keeps track of embryos throughout the in-vitro process at various intervals, as well as provides a record of images, scoring, determinations, environmental conditions, and media and utensils from gamete collection to embryo replacement. It also offers CellCura software solutions, such as Morphology and image capture software that enables the embryologist to document the internal architecture of oocytes and embryos at various stages of their development using measurements and standard scoring parameters; and CellCura Protein Free Media, a culture media, which eliminates the risks of transmission of blood borne diseases. The company is headquartered in Skien, Norway.

2 Employees
Last Reported Date: 05/9/14

cellcura asa (CELL) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

cellcura asa (CELL) Key Developments

CellCura ASA Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

CellCura ASA announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the third quarter, the company reported revenue of NOK 412,000 against NOK 2,440,000 a year ago. Total operating income was NOK 412,000 against NOK 2,440,000 a year ago. Operating loss was NOK 3,361,000 against NOK 5,494,000 a year ago. Loss before tax was NOK 4,420,000 against NOK 5,865,000 a year ago. Loss for the period was NOK 4,319,000 against NOK 5,755,000 a year ago. Basic and diluted loss per share was 0.66 against 0.05 a year ago. LBITDA in the third quarter of 2014 was NOK 1.6 million compared to NOK 3.7 million in the third quarter of 2013. For the nine months, the company reported revenue of NOK 1,423,000 against NOK 4,161,000 a year ago. Total operating income was NOK 1,423,000 against NOK 4,161,000 a year ago. Operating loss was NOK 10,570,000 against NOK 18,936,000 a year ago. Loss before tax was NOK 12,990,000 against NOK 20,294,000 a year ago. Loss for the period was NOK 12,605,000 against NOK 19,975,000 a year ago. Basic and diluted loss per share was 1.93 against 0.25 a year ago. Net cash outflow from operating activities was NOK 7,914,000 against NOK 10,096,000 a year ago. Investment in property plant and equipment was NOK 14,000.

CellCura ASA, Q3 2014 Earnings Call, Nov 28, 2014

CellCura ASA, Q3 2014 Earnings Call, Nov 28, 2014

CellCura ASA, Special/Extraordinary Shareholders Meeting, Nov 21, 2014

CellCura ASA, Special/Extraordinary Shareholders Meeting, Nov 21, 2014., at 10:00 Central European Standard Time. Location: Vika Atrium, Munkedamsveien 45 entrance A. Agenda: To consider the opening of the meeting and registration of the shareholders present; to consider the election of chairman for the meeting and a person to co-sign the minutes; to consider the approval of the notice of the meeting and the agenda; to consider the convertible loan; and to consider the authorization to the board of directors to increase the share capital.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELL:NO 0.30 NOK 0.00

CELL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CELL.
View Industry Companies
 

Industry Analysis

CELL

Industry Average

Valuation CELL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLCURA ASA, please visit www.cellcura.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.